HeartFlow Inc. (HTFL)
NASDAQ
Real-time Data
01:30 PM
Day's Range
48.4452 wk Range
20.13Overview - HTFL - HeartFlow Inc.
Key Statistics
Valuation
Enterprise Value
4.14B
P/E (Trailing)
‪-15.51‬
P/E (Forward)
‪-191.09‬
PEG Ratio
‪-0.26‬
Price / Sales (TTM)
‪20.16‬
Price / Book
‪15.24‬
EV / EBITDA
‪-58.02‬
Profitability
Gross Margin
‪83.00%‬
Profit Margin
‪-55.81%‬
Operating Margin
‪-27.93%‬
Return on Assets
‪-18.05%‬
Return on Equity
‪-154.23%‬
Ownership
Shares Outstanding
86.71M
Float
67.20M
Short % of Shares Outstanding
‪9.36%‬
Held by Insiders
‪5.00%‬
Held by Institutions
‪91.85%‬
Price stats
50-Day Avg
‪39.13‬
200-Day Avg
‪31.17‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 44.78‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HTFL - HeartFlow Inc.
Peers - HTFL - HeartFlow Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - HTFL - HeartFlow Inc.
About
HeartFlow Inc. is a commercial-stage medical technology company focused on non-invasive coronary artery disease diagnosis and management. HeartFlow Inc. develops software and artificial intelligence tools that analyze coronary computed tomography angiography scans to create personalized 3D models of a patient’s heart,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
